All News


Sworn enemies unite against draft EU IP law

Sworn enemies within the technology and pharmaceutical industries are joining forces in a lobbying drive to persuade European Union lawmakers to change a draft law they say will stifle innovation in Europe by criminalising patent infringements, along with all forms of intellectual property infringements.

Sigma-Aldrich goes shopping

Lab-supply companies are normally in the business of selling things to scientists, rather than buying. But the new CEO of Sigma-Aldrich, one of the world's largest lab-supply firms, is shopping for new ideas, new partners - and new companies to invest in.

Cambridge academics vote for new IP plan

Cambridge University is tightening its grip on rights to intellectual property generated by staff and students after academics voted overwhelmingly to endorse new plans

Lab Notes

On inventive Californians, technology transfer, how to approach the business press, and other insights into R&D management.

A test of success

"Anything that won't sell, I don't want to invent. Its sale is proof of utility, and utility is success." Thomas A. Edison (1847-1931).

Staying in the loop

A new Munich-based company that says its patented technologies can reduce household water consumption by 90 per cent on average is looking for more investment.

Yeast collector looks to culture partnerships

The UK's National Collection of Yeast Cultures is looking for partners to help it to delve into research on using yeast to contribute to cutting edge science such as fingerprint DNA identification or drug delivery systems